# Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta Previa

> **NCT03779451** · NA · UNKNOWN · sponsor: **Aswan University Hospital** · enrollment: 400 (estimated)

## Conditions studied

- Placenta Previa

## Interventions

- **DRUG:** 17-OHPC
- **DRUG:** vaginal progesterone

## Key facts

- **NCT ID:** NCT03779451
- **Lead sponsor:** Aswan University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-01
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-04-01
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2019-02-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03779451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03779451, "Vaginal Progesterone Versus 17-Alpha-Hydroxyprogesterone Caproate in Placenta Previa". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03779451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*